Əsas səhifə

Çap

Əks əlaqə

İnfo
Abnormal screening glucose challenge test in pregnancy and future risk of diabetes

Mündəricat

Abnormal screening glucose challenge test in pregnancy and future risk of diabetes

Sübutlu məlumatların xülasələri
24.08.2018 • Sonuncu dəyişiklik 24.08.2018
Editors

An abnormal screening glucose tolerance test in pregnancy appears to increase the future risk of diabetes.

Comment: The quality of evidence is upgraded by large magnitude of effect.

In a population-based, retrospective cohort study 15 381 women referred for an antepartum oral glucose tolerance test (OGTT) indicative of an abnormal 50-g glucose challenge test (GCT), but without GDM, were matched (for age, region, socioeconomic status, and year of delivery) with up to 4 other women without such referral (n = 61 237). The two cohorts were followed over a median 6.4 years for the development of diabetes. The rate of incident DM was 5.04 cases per 1000 person-years in the cohort of women who underwent an antepartum OGTT, compared with 1.74 cases per 1000 person-years in women without an OGTT. The hazard ratio for subsequent DM in women with abnormal GCT was 2.56 (95% CI 2.28 to 2.87, P < 0.0001).

Ədəbiyyat

  1. Retnakaran R, Shah BR. Abnormal screening glucose challenge test in pregnancy and future risk of diabetes in young women. Diabet Med 2009;26(5):474-7.